Immunohistochemical analysis and in situ hybridization of cyclooxygenase-2 expression in intraductal papillary-mucinous tumors of the pancreas

被引:49
|
作者
Niijima, M
Yamaguchi, T
Ishihara, T
Hara, T
Kato, K
Kondo, F
Saisho, H
机构
[1] Chiba Univ, Dept Med 1, Sch Med, Chiba, Japan
[2] Chiba Univ, Dept Pathol 2, Sch Med, Chiba, Japan
关键词
intraductal papillary-mucinous tumor of the pancreas; cyclooxygenase-1 (COX-1); cyclooxygenase-2 (COX-2); proliferating cell nuclear antigen; immunohistochemistry; in situ hybridization;
D O I
10.1002/cncr.10358
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. The objective of this study was to investigate COX-2 expression in intraductal papillary-mucinous tumor of the pancreas (IPMT) using immunohistochemical staining (111) and in situ hybridization (ISH). METHODS. Immunohistochemical staining of COX-2 was performed using samples from 42 patients with IPMT (hyperplasia, 10; adenoma, 13; noninvasive adenocarcinoma, 13; invasive adenocarcinoma, 6) and from 10 patients with ductal pancreatic adenocarcinoma, 10 with chronic pancreatitis, and 6 normal pancreatic tissues as controls. Also, COX-2 was determined in five patients with IPMT noninvasive adenocarcinoma, in whom all histologic types, hyperplasia, adenoma, and adenocarcinoma were observed in the same excised specimens. Furthermore, Ill of proliferating cell nuclear antigen (PCNA) was performed, and the labeling index (LI) was calculated to investigate the correlation with COX-2. To confirm COX-2 mRNA, the authors performed ISH in 20 IPMT patients. RESULTS, COX-2 was positive in 0%, 0%, and 10% of pancreatic duct epithelial cells from normal pancreatic tissue, chronic pancreatitis, and IPMT hyperplasia, respectively. Whereas it was positive in 69%, 77%, 67%, and 80% of IPMT adenoma, IPMT noninvasive adenocarcinoma, IPMT invasive adenocarcinoma, and ductal pancreatic adenocarcinoma, respectively, showing significant differences between IPMT hyperplasia and IPMT adenoma or IPMT adenocarcinoma (noninvasive and invasive adeno carcinoma). In the same patient, COX-2 was negative in the hyperplasia region but positive in adenoma and adenocarcinoma regions, showing results reflecting the progression of the disease. In the COX-2 negative group, PCNA-LI was 19.2 +/- 17.9%, and 33.5 +/- 15.7% in the positive group, a significant difference. On ISH COX-2 mRNA was expressed in three of four and seven of eight COX-2 positive patients with IPMT adenoma and adenocarcinoma, respectively CONCLUSIONS. COX-2 was highly expressed in adenoma and adenocarcinoma in IPMT, showing a relation to the histologic grade of IPMT. (C) 2002 American Cancer Society.
引用
收藏
页码:1565 / 1573
页数:9
相关论文
共 50 条
  • [41] Intraductal papillary mucinous tumors of the pancreas
    Friedrich H. Schmitz-Winnenthal
    Kaspar Z’graggen
    Christine Volk
    Bruno M. Schmied
    Markus W. Büchler
    Current Gastroenterology Reports, 2003, 5 (2) : 133 - 140
  • [42] Intraductal papillary mucinous tumors of the pancreas
    Monneuse, OJY
    Rochette, A
    Pilleul, F
    PRESSE MEDICALE, 2006, 35 (04): : 669 - 678
  • [43] Intraductal papillary mucinous tumors of the pancreas
    Dumitrescu, Daniela
    Popescu, Carmen Florina
    Saftoiu, A.
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2010, 51 (03): : 447 - 453
  • [44] Intraductal papillary mucinous tumors of the pancreas
    Prasad, SR
    Sahani, D
    Nasser, S
    Farrell, J
    Fernandez-Del Castillo, C
    Hahn, PF
    Mueller, PR
    ABDOMINAL IMAGING, 2003, 28 (03): : 357 - 365
  • [45] Intraductal papillary mucinous tumors of the pancreas
    Conlon, KC
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (20) : 4518 - 4523
  • [46] Intraductal papillary mucinous tumors of the pancreas
    Nakagohri, T
    Kenmochi, T
    Kainuma, O
    Tokoro, Y
    Asano, T
    AMERICAN JOURNAL OF SURGERY, 1999, 178 (04): : 344 - 347
  • [47] Intraductal papillary mucinous tumors of the pancreas
    S. R. Prasad
    D. Sahani
    S. Nasser
    J. Farrell
    C. Fernandez-Del Castillo
    P. F. Hahn
    P. R. Mueller
    S. Saini
    Abdominal Imaging, 2003, 28 : 0357 - 0365
  • [48] Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas
    Yamaguchi, K
    Ohuchida, J
    Ohtsuka, T
    Nakano, K
    Tanaka, M
    PANCREATOLOGY, 2002, 2 (05) : 484 - 490
  • [49] The risk of malignancy in intraductal papillary-mucinous tumors of the pancreas (IPMt) depends on disease duration
    Jouannnaud, V
    Levy, P
    Couvelard, A
    Cazels-Hatem, D
    Palazzo, L
    Sauvanet, A
    Maire, F
    O'Toole, D
    Hentic, O
    Hammel, P
    Ruszniewski, P
    GASTROENTEROLOGY, 2004, 126 (04) : A84 - A84
  • [50] Hes-1 and Cox-2 expression in intraductal papillary-mucinous tumor of the pancreas
    Hosotani, R
    Wada, M
    Kajiwara, T
    Miyamoto, Y
    Masui, T
    Fujimoto, K
    Doi, R
    Imamura, M
    GASTROENTEROLOGY, 2003, 124 (04) : A290 - A290